Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
76
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma

Mengxiang Zhao1 Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210093, People’s Republic of China
,
Liang Ding1 Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210093, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1043-0923
ORCID Icon,
Yan Yang2 Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210008, People’s Republic of China
,
Sheng Chen2 Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210008, People’s Republic of China
,
Nisha Zhu1 Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210093, People’s Republic of China
,
Yong Fu1 Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210093, People’s Republic of China
,
Yanhong Ni1 Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210093, People’s Republic of ChinaCorrespondence[email protected]
&
Zhiyong Wang2 Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing210008, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 9553-9562 | Published online: 11 Nov 2019

References

  • Huang TY, Hsu LP, Wen YH, et al. Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol. 2010;46:49–55. doi:10.1016/j.oraloncology.2009.10.01120005769
  • Kernohan MD, Clark JR, Gao K, Ebrahimi A, Milross CG. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg. 2010;136:1235–1239. doi:10.1001/archoto.2010.21421173373
  • Wang L, Zhao M, Guo C, et al. Pdcd4 deficiency aggravated colitis and colitis-associated colorectal cancer via promoting il-6/stat3 pathway in mice. Inflamm Bowel Dis. 2016;22:1107–1118. doi:10.1097/MIB.000000000000072926891257
  • Wu Y, Hu L, Liang Y, et al. Up-regulation of lncRNA casc9 promotes esophageal squamous cell carcinoma growth by negatively regulating pdcd4 expression through ezh2. Mol Cancer. 2017;16:150. doi:10.1186/s12943-017-0715-728854977
  • Pennelli G, Galuppini F, Barollo S, et al. The pdcd4/mir-21 pathway in medullary thyroid carcinoma. Hum Pathol. 2015;46:50–57. doi:10.1016/j.humpath.2014.09.00625316501
  • Shiota M, Izumi H, Tanimoto A, et al. Programmed cell death protein 4 down-regulates y-box binding protein-1 expression via a direct interaction with twist1 to suppress cancer cell growth. Cancer Res. 2009;69:3148–3156. doi:10.1158/0008-5472.CAN-08-233419318582
  • Stoneley M, Willis AE. Eif4a1 is a promising new therapeutic target in er-negative breast cancer. Cell Death Differ. 2015;22:524–525. doi:10.1038/cdd.2014.21025613380
  • Modelska A, Turro E, Russell R, et al. The malignant phenotype in breast cancer is driven by eif4a1-mediated changes in the translational landscape. Cell Death Dis. 2015;6:e1603. doi:10.1038/cddis.2014.54225611378
  • Steinhardt JJ, Peroutka RJ, Mazan-Mamczarz K, et al. Inhibiting card11 translation during BCR activation by targeting the eif4a RNA helicase. Blood. 2014;124:3758–3767. doi:10.1182/blood-2014-07-58968925320244
  • Reis PP, Tomenson M, Cervigne NK, et al. Programmed cell death 4 loss increases tumor cell invasion and is regulated by mir-21 in oral squamous cell carcinoma. Mol Cancer. 2010;9:238. doi:10.1186/1476-4598-9-23820831814
  • Hayashi A, Aishima S, Miyasaka Y, et al. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation. Hum Pathol. 2010;41:1507–1515. doi:10.1016/j.humpath.2010.02.01920656320
  • Desai KM, Kale AD. Immunoexpression of programmed cell death 4 protein in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2017;21:462. doi:10.4103/jomfp.JOMFP_115_17
  • Wei NA, Liu SS, Leung TH, et al. Loss of programmed cell death 4 (pdcd4) associates with the progression of ovarian cancer. Mol Cancer. 2009;8:70. doi:10.1186/1476-4598-8-7019728867
  • Wang Y, Liu Z, Shen J. MicroRNA-421-targeted pdcd4 regulates breast cancer cell proliferation. Int J Mol Med. 2018. doi:10.3892/ijmm
  • Zhen Y, Li D, Li W, et al. Reduced pdcd4 expression promotes cell growth through pi3k/akt signaling in non-small cell lung cancer. Oncol Res. 2016;23:61–68. doi:10.3727/096504015X14478843952861
  • Lu Y, Han B, Yu H, Cui Z, Li Z, Wang J. Berberine regulates the microRNA-21-itgbeta4-pdcd4 axis and inhibits colon cancer viability. Oncol Lett. 2018;15:5971–5976. doi:10.3892/ol.2018.799729564000
  • Wang Q, Yang HS. The role of pdcd4 in tumour suppression and protein translation. Biol Cell. 2018. doi:10.1111/boc.201800014
  • Lim YC, Kang HJ, Kim YS, Choi EC. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of wnt/beta-catenin pathway. Eur J Cancer. 2012;48:3310–3318. doi:10.1016/j.ejca.2012.04.01322640830
  • Gan CP, Hamid S, Hor SY, et al. Valproic acid: growth inhibition of head and neck cancer by induction of terminal differentiation and senescence. Head Neck. 2012;34:344–353. doi:10.1002/hed.v34.321438066
  • Ozpolat B, Akar U, Steiner M, et al. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol Cancer Res. 2007;5:95–108. doi:10.1158/1541-7786.MCR-06-012517259349
  • Lingel H, Wissing J, Arra A, et al. CTLA-4-mediated posttranslational modifications direct cytotoxic t-lymphocyte differentiation. Cell Death Differ. 2017;24:1739–1749. doi:10.1038/cdd.2017.10228644433
  • Shankaran V, Ikeda H, Bruce AT, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410:1107–1111. doi:10.1038/3507412211323675

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.